Abionic SA Revenue and Competitors
Estimated Revenue & Valuation
- Abionic SA's estimated annual revenue is currently $6.2M per year.
- Abionic SA's estimated revenue per employee is $155,000
Employee Data
- Abionic SA has 40 Employees.
- Abionic SA grew their employee count by -33% last year.
Abionic SA's People
Name | Title | Email/Phone |
---|
Abionic SA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Abionic SA?
Abionic, an in vitro diagnostics (IVD) company, was founded in 2010 as a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL). Abionic is aiming to make a difference in patient care through the cutting-edge nanofluidic technology based ultra-rapid diagnostic platform, helping healthcare professionals to make clinical decisions at the point of care.
keywords:N/AN/A
Total Funding
40
Number of Employees
$6.2M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Abionic SA News
2022-04-17 - IgE Allergy Blood Tests Market 2022 Development Status ...
Some of the Major Key players profiled in the study are Abionic SA, Amerimmune LLC, AXO Science SAS, Biovator AB (Inactive),...
2022-04-13 - Biomedical Nanotechnology Market Growth Improvement ...
Some of the key players profiled in the study are: Altairnano (United States), Park Systems Corp (South Korea), HORIBA, Ltd. (Japan), Abionic SA...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.9M | 52 | 27% | N/A |
#2 | $28.8M | 187 | 32% | N/A |